Intriguingly, the degradation of ERK5 induced by INY-06-061 did not lead to anti-proliferative effects in multiple cancer cell lines, nor did it suppress inflammatory responses in ECs, in contrast to the outcomes observed with genetic knockdown of ERK5. Here, MAPK7 is linked to cancer.